Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.3%

9 terminated/withdrawn out of 73 trials

Success Rate

74.3%

-12.2% vs industry average

Late-Stage Pipeline

8%

6 trials in Phase 3/4

Results Transparency

58%

15 of 26 completed trials have results

Key Signals

15 recruiting15 with results7 terminated

Enrollment Performance

Analytics

Phase 1
59(83.1%)
Phase 3
6(8.5%)
Phase 2
5(7.0%)
Early Phase 1
1(1.4%)
71Total
Phase 1(59)
Phase 3(6)
Phase 2(5)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (73)

Showing 20 of 73 trials
NCT07451613Phase 1Recruiting

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Role: collaborator

NCT05135091Phase 3Recruiting

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Role: collaborator

NCT06557460Phase 2Recruiting

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Role: collaborator

NCT04119024Phase 1Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Role: collaborator

NCT06186401Phase 1Recruiting

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Role: collaborator

NCT06504381Phase 1Recruiting

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

Role: collaborator

NCT03977662Phase 1Completed

Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes

Role: collaborator

NCT03249831Phase 1Active Not Recruiting

A Blood Stem Cell Transplant for Sickle Cell Disease

Role: collaborator

NCT03741127Phase 1Active Not Recruiting

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

Role: collaborator

NCT03957954Phase 1Active Not Recruiting

Stem Cell Therapy for Limbal Stem Cell Deficiency

Role: collaborator

NCT04196413Phase 1Recruiting

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

Role: collaborator

NCT07106021Phase 1Recruiting

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

Role: collaborator

NCT04652908Phase 1Recruiting

Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial

Role: collaborator

NCT03897361Phase 1Completed

Stem Cell Gene Therapy for Cystinosis

Role: collaborator

NCT04640987Phase 1Recruiting

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback

Role: collaborator

NCT02247843Phase 1Completed

Stem Cell Gene Therapy for Sickle Cell Disease

Role: collaborator

NCT05421689Phase 1Active Not Recruiting

Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia

Role: collaborator

NCT04497779Active Not Recruiting

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Role: collaborator

NCT03183245Phase 3Completed

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Role: collaborator

NCT03233854Phase 1Active Not Recruiting

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Role: collaborator